Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Alcohol use disorder affects approximately 29 million adults in the United States, yet fewer than 10 percent receive any form of treatment. The medications currently available — naltrexone, acamprosate, and disulfiram — have modest effect sizes and high discontinuation rates. Relapse rates remain stubbornly high, often exceeding 60 percent within the first year. Against this backdrop, a novel approach combining ketamine with psychological techniques has produced some of the most striking results the addiction field has seen in recent years.
A 2019 study by Das RK and colleagues, published in Nature Communications, tested a creative hypothesis: could ketamine be used to weaken maladaptive reward memories associated with drinking? The researchers recruited 90 participants with hazardous drinking patterns and used a memory reactivation paradigm — briefly presenting beer-related cues to "destabilize" drinking-related memories — followed by a single intravenous dose of ketamine. The idea was that ketamine, through its NMDA receptor antagonism, could interfere with the reconsolidation of these reactivated memories, effectively weakening the learned associations between alcohol cues and the urge to drink.
The results were notable. Participants who received both memory reactivation and ketamine showed significant reductions in the urge to drink, the rewarding properties of alcohol, and overall alcohol consumption over a nine-month follow-up period. Importantly, these effects were specific to the combination — ketamine alone or memory reactivation alone did not produce the same magnitude of change. The group receiving the combined intervention reduced their weekly drinking days and total alcohol consumption significantly more than control groups.
This study builds on earlier work by Dakwar and colleagues exploring ketamine's effects on substance use. A 2012 study by Dakwar E and colleagues, published in Biological Psychiatry (PMID: 22502987), demonstrated that subanesthetic ketamine reduced motivation to use cocaine and diminished cue-induced craving in cocaine-dependent volunteers. Together, these studies suggest ketamine may have broader anti-craving properties that extend across different substances of abuse, possibly by modulating reward circuitry and disrupting entrenched patterns of substance-related learning.
The reconsolidation-based approach is particularly interesting because it targets the root of habitual behavior rather than simply managing symptoms. Most current addiction treatments work by blocking receptors (naltrexone), creating aversive reactions (disulfiram), or stabilizing neurotransmitter systems (acamprosate). None of them directly address the powerful associative memories that drive craving and relapse — the sight of a bar, the sound of a bottle opening, the social context that triggers the urge to drink.
From a physician's perspective, the Das et al. findings suggest a potential paradigm shift: rather than indefinite pharmacological maintenance, a brief targeted intervention might produce lasting changes in how the brain responds to alcohol cues. However, these results come from a relatively small sample of hazardous drinkers rather than individuals with severe alcohol use disorder, and replication in clinical populations is essential before this becomes standard practice.
If you are struggling with alcohol use disorder, it is important to understand that ketamine is not currently an approved treatment for addiction. The research described here is promising but still in early stages. Any use of ketamine for substance use concerns would be off-label and should only occur under the supervision of a qualified physician who can assess your full clinical picture.
That said, the overlap between depression and alcohol use disorder is substantial — roughly one-third of people with alcohol use disorder also meet criteria for major depression. For patients dealing with both conditions, ketamine's potential to address depressive symptoms rapidly may provide a more stable foundation from which to engage in recovery efforts, including therapy and support groups.
Emerging research suggests ketamine may reduce alcohol cravings and consumption, particularly when combined with psychological techniques that target maladaptive reward memories. While this approach is not yet ready for routine clinical use, it represents a genuinely novel direction in addiction treatment that addresses the learned associations driving relapse.
References: Das RK, et al. "Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories." Nature Communications. 2019;10:5187. DOI: 10.1038/s41467-019-13162-w. | Dakwar E, et al. "The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers." Biological Psychiatry. 2012;76(1):40-46. PMID: 22502987.
If you're considering ketamine therapy, Isha Health offers physician-led at-home treatment via telemedicine in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, and Washington. No in-person visit required.
